Exicure (NASDAQ:XCUR) Stock Price & Analysis

–

USD

–(–)

Open

$1.995

Prev. Close

$1.37

High

$1.995

Low

$1.94

Company Profile

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

CEOJungsoo Kim

SectorHealthcare

IndustryBiotechnology

Employees8

IPO DateMay 22, 2018

ExchangeNASDAQ

Exchange NameNASDAQ Capital Market

CurrencyUSD

Headquarters & Contact

Address400 Seaport Court

City / State / ZIPRedwood City, CA, 94063

CountryUnited States

Phone847 673 1700

Websitehttps://www.exicuretx.com

Exicure, Inc.

Company Profile

Recently from Cashu